Lista de obras -

Acetylated bacterial proteins as potent antigens inducing an anti-modified protein antibody response

Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity

artículo científico publicado en 2020

Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications

artículo científico publicado en 2020

Body mass index and treatment survival in patients with RA starting treatment with TNFα-inhibitors: long-term follow-up in the real-life METEOR registry

artículo científico publicado en 2020

Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib

artículo científico publicado en 2020

Determinants of absence of osteoarthritis in old age ⬇️

artículo científico publicado el 5 de octubre de 2010

Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair ⬇️

artículo científico publicado el 1 de abril de 2003

Disruptive innovation in rheumatology: new networks of global public-private partnerships are needed to take advantage of scientific progress

scientific article published on 05 March 2020

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

artículo científico publicado en 2020

Earlier is better when treating rheumatoid arthritis: but can we detect a window of opportunity?

artículo científico publicado en 2020

Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis ⬇️

artículo científico publicado el 1 de mayo de 2003

IgM antibodies against acetylated proteins as a possible starting point of the anti-modified protein antibody response in rheumatoid arthritis

Increasing incidence of autoantibody-negative RA is replicated and is partly explained by an aging population

artículo científico publicado en 2020

Machine Learning Electronic Health Record Identification of Patients with Rheumatoid Arthritis: Algorithm Pipeline Development and Validation Study

scientific article published on 30 November 2020

Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis ⬇️

artículo científico publicado el 1 de noviembre de 2003

Persistently activated, proliferative memory autoreactive B cells promote inflammation in rheumatoid arthritis

artículo científico publicado en 2020

Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study

artículo científico publicado en 2020

Surface Ig variable domain glycosylation affects autoantigen binding and acts as threshold for human autoreactive B cell activation

artículo científico publicado en 2022

Using genetics to prioritize diagnoses for rheumatology outpatients with inflammatory arthritis

artículo científico publicado en 2020

Lista de obras de

Acetylated bacterial proteins as potent antigens inducing an anti-modified protein antibody response

Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity

Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications

Body mass index and treatment survival in patients with RA starting treatment with TNFα-inhibitors: long-term follow-up in the real-life METEOR registry

Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib

Determinants of absence of osteoarthritis in old age ⬇️

Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair ⬇️

Disruptive innovation in rheumatology: new networks of global public-private partnerships are needed to take advantage of scientific progress

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Earlier is better when treating rheumatoid arthritis: but can we detect a window of opportunity?

Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis ⬇️

IgM antibodies against acetylated proteins as a possible starting point of the anti-modified protein antibody response in rheumatoid arthritis

Increasing incidence of autoantibody-negative RA is replicated and is partly explained by an aging population

Machine Learning Electronic Health Record Identification of Patients with Rheumatoid Arthritis: Algorithm Pipeline Development and Validation Study

Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis ⬇️

Persistently activated, proliferative memory autoreactive B cells promote inflammation in rheumatoid arthritis

Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study

Surface Ig variable domain glycosylation affects autoantigen binding and acts as threshold for human autoreactive B cell activation

Using genetics to prioritize diagnoses for rheumatology outpatients with inflammatory arthritis